ISSN: 0975-0851
Statistical considerations in biosimilar assessment using biosimilarity index
In-vitro Release of Rapamycin from a Thermosensitive Polymer for the Inhibition of Vascular Smooth Muscle Cell Proliferation
View More »
Journal of Bioequivalence & Bioavailability received 4890 citations as per Google Scholar report
Review Article
Mechanism of Oxaliplatin-Induced Sinusoidal Obstruction Syndrome along with Therapeutic Strategy
DOI: 10.35248/0975-0851.24.16.584
Research Article
Models, Optimal Sampling and Bioequivalence-A New Paradigm Case Study for a Drug with Complex Absorption Modified Release Methylphenidate
DOI: 10.35248/0975-0851.24.16.583.
Perspective
Improving Drug Evaluation Processes through Conventional and Innovative Bioequivalence Testing Developments
DOI: 10.35248/0975-0851.24.16.575
Significance of Bioequivalence in the Development of Generic Drugs
DOI: 10.35248/0975-0851.24.16.576
Developments and Challenges for Bioavailability and Bioequivalency
DOI: 10.35248/0975-0851.24.16.577
Commentary Article
Generic Drug Development and Advancements in Blood Sampling for Bioequivalence Studies
DOI: 10.35248/0975-0851.24.16.578
Generic and Biosimilar Drug Interchangeability and Innovations
DOI: 10.35248/0975-0851.24.16.579
Opinion Article
Applications for Clinical Innovation in the Management of Highly Variable Drug Complexities
DOI: 10.35248/0975-0851.24.16.580
Bioequivalence in Cancer Therapy and Effective Treatment through Advanced Research
DOI: 10.35248/0975-0851.24.16.582
Scaled Average Bioequivalency and Advancements in Generic Drug Development
DOI: 10.35248/0975-0851.24.16.581.